FDA Approved: LUPKYNIS — Supplemental Application (Aurinia Pharma U.S., Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LUPKYNIS (voclosporin) submitted by Aurinia Pharma U.S., Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• LUPKYNIS (voclosporin)

Snippet

SUPPL AP for LUPKYNIS (VOCLOSPORIN)